文献速递前列腺癌

机器人辅助根治性前列腺切除术后生化复发的手术学习曲线

The Surgical Learning Curve for Biochemical Recurrence After Robot-assisted Radical Prostatectomy.
PubMed 文献 · Eur Urol Oncol · 2022-07-15

该回顾性多中心研究纳入2003至2021年间9家机构46名术者实施的8101例机器人辅助根治性前列腺切除术患者,分析术者既往手术经验与术后生化复发的关系。校正病例组合后,手术经验与生化复发风险的关系无统计学显著差异(p=0.2);既往10、250和1000例手术经验对应的5年生化复发无生存率分别为82.0%、82.7%和84.8%。

要点

  • 校正病例组合后,术者手术经验与RARP术后生化复发风险无统计学显著关联(p=0.2)。
  • 既往10、250、1000例经验对应的5年无生化复发生存率分别为82.0%、82.7%、84.8%。
  • 既往10例与1000例经验者5年无生化复发绝对差异为1.6%(95%CI:0.4%,3.3%)。

核心结论

  • 与开放和腹腔镜根治性前列腺切除术不同,机器人辅助根治性前列腺切除术术者在职业生涯早期即可获得充分的肿瘤控制。

研究设计与样本

  • 回顾性分析2003至2021年间9家机构46名术者实施的8101例机器人辅助根治性前列腺切除术患者数据。
  • 手术经验以患者手术前术者累计完成的机器人前列腺切除术总数编码。

主要发现

  • 共1047例患者出现生化复发,无生化复发患者的中位随访时间为33个月(四分位距:14,61)。
  • 校正术前前列腺特异性抗原、病理分期、分级、淋巴结受累和手术年份后,手术经验与术后生化复发风险的关系无统计学显著差异(p=0.2)。
  • 既往10、250和1000例手术经验对应的5年无生化复发生存率分别为82.0%、82.7%和84.8%,既往10例与1000例之间的绝对差异为1.6%(95%CI:0.4%,3.3%)。

关键数值与推荐

  • 校正病例组合后手术经验与生化复发风险的关系无统计学显著差异(p=0.2)。
  • 既往10、250、1000例手术经验对应的5年无生化复发生存率分别为82.0%、82.7%、84.8%。
  • 既往10例与1000例手术经验的5年无生化复发绝对差异为1.6%(95%CI:0.4%,3.3%)。

临床怎么用

  • 原文未据此给出推荐,作者在结论中提出进一步研究应探索机器人手术学习曲线与开放及腹腔镜根治性前列腺切除术既往发现不同的原因。
  • 作者假设包括模拟训练和采用客观性能指标在内的外科教育是使学习曲线变平的重要机制。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Improved cancer control with increasing surgical experience-the learning curve-was demonstrated for open and laparoscopic prostatectomy. In a prior single-center study, we found that this might not be the case for robot-assisted radical prostatectomy (RARP). OBJECTIVE: To investigate the relationship between prior experience of a surgeon and biochemical recurrence (BCR) after RARP. DESIGN, SETTING, AND PARTICIPANTS: We retrospectively analyzed the data of 8101 patients with prostate cancer treated with RARP by 46 surgeons at nine institutions between 2003 and 2021. Surgical experience was coded as the total number of robotic prostatectomies performed by the surgeon before the patient operation. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: We evaluated the relationship of prior surgeon experience with the probability of BCR adjusting for preoperative prostate-specific antigen, pathologic stage, grade, lymph-node involvement, and year of surgery. RESULTS AND LIMITATIONS: Overall, 1047 patients had BCR. The median follow-up for patients without BCR was 33 mo (interquartile range: 14, 61). After adjusting for case mix, the relationship between surgical experience and the risk of BCR after surgery was not statistically significant (p = 0.2). The 5-yr BCR-free survival rates for a patient treated by a surgeon with prior 10, 250, and 1000 procedures performed were, respectively, 82.0%, 82.7%, and 84.8% (absolute difference between 10 and 1000 prior procedures: 1.6% [95% confidence interval: 0.4%, 3.3%). Results were robust to a number of sensitivity analyses. CONCLUSIONS: These findings suggest that, as opposed to open and laparoscopic radical prostatectomy, surgeons performing RARP achieve adequate cancer control in the early phase of their career. Further research should explore why the learning curve for robotic surgery differs from prior findings for open and laparoscopic radical prostatectomy. We hypothesize that surgical education, including simulation training and the adoption of objective performance metrics, is an important mechanism for flattening the learning curve. PATIENT SUMMARY: We investigated the relationship between biochemical recurrence after robot-assisted radical prostatectomy and surgeon's experience. Surgeons at an early stage of their career had similar outcomes to those of more experienced surgeons, and we hypothesized that surgical education in robotics might be an important determinant of such a finding.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Bravi CA, Dell'Oglio P, Mazzone E, et al. The Surgical Learning Curve for Biochemical Recurrence After Robot-assisted Radical Prostatectomy. Eur Urol Oncol. 2022. PMID: 35850976. doi:10.1016/j.euo.2022.06.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。